MediaVantage provides the tools and intelligence your business needs to measure your PR success. With in-depth reporting and collaboration tools, MediaVantage is your secure solution for reputation management.
Our solution brings together traditional and social media content in a single platform, which means you can extract valuable information with speed and ease.
To view Multimedia News Release, go to http://www.multivu.com/players/English/59179-mediavantage-be-in-control-of-your-brand/
BioPharmX Corporation (OTCQB: BPMX) today announced the availability of Violet™ iodine, a new, once-daily pill for relief of premenstrual breast discomfort. The first-of-its-kind product is based on the latest molecular iodine technology designed to help free women from the burden of breast discomfort by addressing the underlying causes of a condition known as fibrocystic breast condition (FBC), with the added benefit of promoting breast health for women of reproductive age.*
*These statements have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7378951-biopharmx-introducing-violet-iodine-premenstrual-breast-discomfort/
Consumers who choose a 2017 TOP SAFETY PICK+ award winner shouldn’t have trouble seeing the road on nighttime drives. Good or acceptable ratings in the Insurance Institute for Highway Safety’s new headlight evaluations set the latest crop of qualifiers apart. Thirty-eight models earn the “plus” accolade, and 44 earn TOP SAFETY PICK.
IIHS toughened the criteria for TOP SAFETY PICK+ to reflect new headlight evaluations launched in 2016. The recognition program is meant to encourage manufacturers to offer state-of-the-art protection for people in crashes, along with features that help drivers avoid crashes in the first place. In addition to good or acceptable headlights, the latter includes automatic braking technology, which has been part of the criteria since 2015.
For both awards, models must earn good ratings in the Institute’s small overlap front, moderate overlap front, side, roof strength and head restraint tests, as well as an advanced or superior rating for front crash prevention with standard or optional autobrake. Headlights are factored in only for the top award.
Atmel® Corporation (NASDAQ: ATML), a leader in microcontroller and touch technology solutions, today announced its popular Tech On Tour (ToT) is hitting the road in a 40' x 85' mobile trailer, which opens out into a 900 square feet walk-in space.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60066-atmel-tech-on-tour-mobile-trailer-showcase-hardware-software
ConnXus, a supplier diversity technology platform, today announced that it has closed $5 million in Series “A” funding, led by Techstars Ventures, Serious Change L.P. and Impact America Fund.
“This round of funding will significantly accelerate ConnXus’ long-term impact on generating sustainable and diverse supply chains,” said Rod Robinson, CEO and founder of ConnXus. “To date we’ve raised $10 million in investments, including participation from Techstars Ventures, CincyTech, Serious Change L.P., Impact America Fund, and several private angel investors.”
ConnXus’ cloud-based, supplier diversity sustainability dashboards open the door for procurement, supplier diversity, and supply chain professionals to access a wealth of global supply chain analytics. Robinson believes Techstars and the other investors are the right investors for the company to disrupt and add imperative value to the $10-billion supply chain and procurement software market.
To view the multimedia release go to:
http://www.multivu.com/players/English/7834951-connxus-five-million-series-a/
Varian Medical Systems (NYSE: VAR) today is introducing the Halcyon™ system, an entirely new device for cancer treatment. Engineered to revolutionize clinical workflow, Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT). This new treatment system is designed to expand the availability of high quality cancer care globally and help save the lives of millions more cancer patients.
“The global cancer challenge is enormous,” said Kolleen Kennedy, president of Varian's Oncology Systems business. “It is expected that there will be 24.6 million cancer cases diagnosed annually by 2030, and there is an acute shortage of equipment and trained clinicians. With the innovations in this new technology platform, the system will deliver high quality Halcyon treatments that empower clinicians to care for many more patients. At Varian we are very excited with the introduction of Halcyon to be taking another big step toward advancing cost-effective cancer care worldwide.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8065951-varian-medical-systems-halcyon-cancer-treatment/
Lamp Lights Are Seen Over The Fake Model Moon.
ALL NASA FOOTAGE USED IN THIS VIDEO IS PUBLIC DOMAIN. THE USE OF ANY COPYRIGHTED MATERIAL IS USED UNDER THE GUIDELINES OF "FAIR USE" IN TITLE 17 § 107 OF THE UNITED STATES CODE. SUCH MATERIAL REMAINS THE COPYRIGHT OF THE ORIGINAL HOLDER AND IS USED HERE FOR THE PURPOSES OF EDUCATION, COMPARISON, AND CRITICISM ONLY. NO INFRINGEMENT OF COPYRIGHT IS INTENDED.
Clayton, one of the largest builders of manufactured, modular and site-built homes combined in America, has released a series of videos that highlights the stories of its team members and their experiences working for the company over the years in their various job roles.
The “I am Clayton” video series shares the different steps it takes to help a customer achieve homeownership through the words of Clayton employees at every touchpoint. The series features testimonials from the real people who work day-in and day-out to contribute to building some of the best quality, affordable homes in the U.S. The videos cast team members who work in several different areas—from home builders to website developers—and allows them to tell their Clayton story in their own words.
To view the multimedia release go to:
http://www.multivu.com/players/English/7716459-clayton-homes-i-am-clayton-video-series/
The holiday season is right around the corner and with it comes celebrating age old traditions with family, friends and loved ones. It’s also time to start planning how to pick out the perfect gift for everyone on your list. This year, the easiest way to WOW is to plug your loved ones in with all of the new tech options available on the market!
Nationally recognized consumer trends and technology expert Andrew Krasny has figured out the puzzle giving gifts that are a hit every time.
Remote Control Cable Trackers Seen Above The Astronaut in The Nevada Fake Moon Bay.
ALL NASA FOOTAGE USED IN THIS VIDEO IS PUBLIC DOMAIN. THE USE OF ANY COPYRIGHTED MATERIAL IS USED UNDER THE GUIDELINES OF "FAIR USE" IN TITLE 17 § 107 OF THE UNITED STATES CODE. SUCH MATERIAL REMAINS THE COPYRIGHT OF THE ORIGINAL HOLDER AND IS USED HERE FOR THE PURPOSES OF EDUCATION, COMPARISON, AND CRITICISM ONLY. NO INFRINGEMENT OF COPYRIGHT IS INTENDED.
St. Jude Children’s Research Hospital® officials and guests today marked the opening of the St. Jude Red Frog Events Proton Therapy Center, the first proton therapy center in the world dedicated solely to children with cancer.
Patients are now being treated at the center using precisely delivered, high-energy particles called protons to kill or shrink tumors while minimizing damage to healthy tissue and organs. For patients with brain tumors and certain other cancers, research suggests proton beam therapy may be more effective than conventional radiation at preventing the growth and spread of tumors while reducing the risk of treatment-related side effects.
To view the multimedia release go to:
http://www.multivu.com/players/English/7713451-st-jude-proton-therapy-opening/
Research from CEB (NYSE: CEB), a best practice insight and technology company and the creators of the Challenger™ Selling model, shows that 51 percent of customers who might be willing to buy from a supplier are not willing to advocate for them and help them get deals over the finish line. This is a direct result of the difficult, internal buying process. Unfortunately, sales organizations lack a true understanding of their customers and are unable to simplify the complexities of buying for them.
“Willingness to buy is not the same as willingness to advocate; suppliers need customers to advocate and fight for them to get deals done today,” said Brent Adamson, principal executive advisor at CEB and co-author of The Challenger Sale and The Challenger Customer. “In order to move past ‘good enough’ and ‘status quo,’ suppliers need to go beyond just understanding how customers interact with them, to gaining a thorough understanding of how they work, what is important to them and how they interact with each other.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7427254-ceb-challenge-align-prescribe-b2b-sales-strategy/
